Envoy Medical (COCH) Profit After Tax (2021 - 2026)

Envoy Medical has disclosed Profit After Tax across 6 years of filings, most recently posting -$4.4 million for Q1 2026.

• Profit After Tax for Q1 2026 came in at -$4.4 million, up 12.95% year-over-year; the trailing twelve-month figure through Mar 2026 was -$23.1 million (down 18.37% YoY), and the FY2025 annual result was -$23.8 million, down 14.24% from the prior year.
• Profit After Tax came in at -$4.4 million for Q1 2026 at Envoy Medical, up from -$6.6 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $1.6 million in Q3 2023 to a low of -$13.3 million in Q2 2023.
• The 5-year median for Profit After Tax is -$5.0 million (2025), against an average of -$5.6 million.
• Peak annual rise in Profit After Tax reached 216.73% in 2023, while the deepest fall reached 979.05% in 2023.
• Envoy Medical's Profit After Tax stood at -$11.5 million in 2022, then jumped by 57.35% to -$4.9 million in 2023, then advanced by 5.66% to -$4.6 million in 2024, then slumped by 42.62% to -$6.6 million in 2025, then jumped by 33.94% to -$4.4 million in 2026.
• The last three Profit After Tax figures came in at -$4.4 million (Q1 2026), -$6.6 million (Q4 2025), and -$6.5 million (Q3 2025), per Business Quant data.